News

American Bio Medica, a biotechnology company, has received notification from the US Patent & Trademark office that it will be granted two new patents; one for its oral

BioDelivery Sciences International, a specialty pharmaceutical company, has announced preliminary results from a Phase I study assessing two new formulations of the opioid analgesic buprenorphine utilizing the company’s

NeurogesX, a biopharmaceutical company, has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion recommending approval of Qutenza for

India-based pharmaceutical company Dr Reddy’s Laboratories has realigned its global generics finished dosages strategy to focus on certain key geographies and would gradually exit some of the very

Nordhoff, who has led Gen-Probe since 1994, will become non-executive chairman upon his re-election to the board by stockholders at the company’s 2009 annual meeting. “I’m delighted to

Neoprobe, a biomedical company, has announced that a multicenter Phase III study of Lymphoseek has reached the accrual of 203 lymph nodes, the study’s primary accrual objective. The

He will also assist in the selection of new product candidates and licensing opportunities for Fujirebio Diagnostics products. He has held various positions at Abbott and Meridian Bioscience,

Warner Chilcott, a specialty pharmaceutical company, has announced that one of its subsidiaries and Mayne Pharma International have filed a second lawsuit against Impax Laboratories, in the District

The company has also announced that it will concentrate its cash resources on the clinical and commercial development of its late-stage oncology candidate, picoplatin. The company continues to